Phesi 'cracks the code' on validating sites' enrollment potential
Excessive costs cost and time to market in clinical trials could soon be eliminated thanks to the addition of a patient access store (PAS) to Phesi's trial accelerator platform.
Source: outsourcing-pharma.com